Brazil's national health watchdog, Anvisa, decided on July 6 to maintain its ban on the import, advertising and sale of e-cigarettes in Brazil. The restrictions started in 2009, but e-cigarettes continue to be marketed illegally in the country, so Anvisa also called for increased inspections and education campaigns to curb the illicit trade in e-cigarettes.

The decision was made unanimously at the agency's collegiate committee meeting.

According to Anvisa Director Cristiane Rose Jourdan, scientific research shows that the use of electronic smoking devices increases the risk of smoking in young people, the likelihood of dependence, and the likelihood of pulmonary, cardiovascular and neurological health problems.

The Brazilian Medical Association (AMB) applauded Anvisa's position.

"This is a wise decision as there is growing scientific evidence that the use of electronic smoking devices DEF is not harmless, does not support smoking cessation or a form of harm reduction, but is a product that can lead to dependence and can Causes many diseases, especially cardiovascular disease, respiratory disease and cancer,” said Ricardo Meirelles, coordinator of the AMB Committee on Combating Tobacco.

According to a survey conducted in the first quarter of 2022 by Vital Strategies and the Federal University of Pelotas, 19.7% of Brazilians aged 18 to 24 have tried e-cigarettes.

BAT Brasil, formerly Souza Cruz, said it will evaluate the regulatory impact analysis when Anvisa's decision is published.

The company cited the U.S., European Union and U.K. among others in a statement.

Japan Tobacco International regrets Anvisa's decision.

"The use of electronic devices in the country is up-to-date and provided entirely by illegal trade. Legalized companies do not sell products, and consumption growth affecting the population comes from illegal purchases of equipment," the company said.